Artificial Intelligence

Atera's new AI agent, Robin, aims to autonomously resolve tech issues, backed by a 'Let People Work' campaign. Can it truly end the IT helpdesk ticket?

Employer confidence is back to 2022 levels, but a new survey reveals AI's uneven impact and hiring plans were made before new geopolitical tensions.

Simpro Group hires Beth Erickson as CHRO to lead a 1,000+ employee expansion, cementing its AI market leadership and making Miami a key tech hub.

The digital art firm secured new capital, but a severe market backlash raises questions about its strategy and path forward in the competitive NFT space.

A new study reveals communications pros are gaining unprecedented C-suite power but feel unprepared for an AI-driven future, risking a major talent exodus.

A new strategic partnership aims to solve the data fragmentation crisis in mining and energy, paving the way for true AI-driven efficiency and safety.

With a Diamond award for its AI assistant SAMI, eschbach is pioneering human-machine collaboration, setting a new standard for safety and efficiency.

A strategic deal sees automotive safety tech repurposed for a booming defense market, targeting threats where traditional optical sensors fail.

As price wars and new tech reshape telecom, Cogeco's CEO will outline the firm's strategy for growth, fiber expansion, and its new flanker brands.

Confluent Cloud for Government has achieved FedRAMP Moderate authorization, enabling federal agencies to adopt real-time data streaming to modernize services.

Dechert's hire of ex-Microsoft and Google counsel J.J. Jones highlights a fierce battle among law firms for talent to navigate the AI legal frontier.

Newtek Bank launches a seven-day business loan up to $350k, using AI to offer a 10-year term that directly challenges high-cost, short-term financing.

GoTo's new AI-powered platform aims to streamline patient communications for small clinics by integrating voice, SMS, and scheduling into one secure system.

Aravo launches its Advantage service to fix a costly enterprise problem: third-party risk programs that stall and fail to deliver on their promise.

New analysis of Phase 1 data for NKGen Biotech’s troculeucel suggests cognitive benefits, offering a potential new weapon against neuroinflammation.

After its Alzheimer's drug failed amidst controversy, Cassava Sciences rebrands as Filana Therapeutics, betting its future on a rare epilepsy disorder.

With its new Disaggregated Spine architecture and ultra-efficient switches, Nexthop AI aims to slash costs and power use for hyperscalers and NeoClouds.

In a tough PE climate, Truelink Capital rapidly closes its second fund at its $2B hard cap, signaling strong investor belief in its operational strategy.

Greenway Health launches Novare, an AI-native system aiming to replace legacy EHRs and eliminate administrative burnout. Is this the future of medicine?

A new report shows automakers are racing to innovate with AI, but a troubling decline in safety standard adherence puts the industry at a critical crossroads.